Private Wealth Partners LLC Buys 28,031 Shares of Pfizer Inc. $PFE

Private Wealth Partners LLC grew its stake in shares of Pfizer Inc. (NYSE:PFE) by 4.9% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 604,878 shares of the biopharmaceutical company’s stock after buying an additional 28,031 shares during the period. Pfizer accounts for 1.3% of Private Wealth Partners LLC’s portfolio, making the stock its 23rd largest position. Private Wealth Partners LLC’s holdings in Pfizer were worth $16,985,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Horizon Financial Services LLC increased its stake in Pfizer by 174.8% in the fourth quarter. Horizon Financial Services LLC now owns 1,014 shares of the biopharmaceutical company’s stock valued at $25,000 after acquiring an additional 645 shares during the last quarter. Godfrey Financial Associates Inc. bought a new stake in Pfizer during the fourth quarter worth about $26,000. YANKCOM Partnership purchased a new position in shares of Pfizer in the 4th quarter worth about $28,000. HFM Investment Advisors LLC increased its position in shares of Pfizer by 61.0% during the 4th quarter. HFM Investment Advisors LLC now owns 1,127 shares of the biopharmaceutical company’s stock valued at $28,000 after purchasing an additional 427 shares during the last quarter. Finally, Evolution Wealth Management Inc. increased its position in shares of Pfizer by 132.2% during the 1st quarter. Evolution Wealth Management Inc. now owns 994 shares of the biopharmaceutical company’s stock valued at $28,000 after purchasing an additional 566 shares during the last quarter. 68.36% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on PFE. HSBC boosted their target price on Pfizer from $29.00 to $32.00 and gave the stock a “buy” rating in a research report on Tuesday, March 17th. Wolfe Research reissued an “underperform” rating and set a $26.00 price target on shares of Pfizer in a research note on Thursday, May 14th. Cantor Fitzgerald restated a “neutral” rating on shares of Pfizer in a report on Monday, June 1st. Bank of America cut their price objective on shares of Pfizer from $27.00 to $26.00 and set a “neutral” rating for the company in a research note on Thursday, April 9th. Finally, BMO Capital Markets reaffirmed an “outperform” rating on shares of Pfizer in a report on Tuesday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, twelve have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, Pfizer has an average rating of “Hold” and a consensus target price of $28.82.

Pfizer Trading Down 0.1%

NYSE PFE opened at $24.29 on Friday. The firm has a market cap of $138.45 billion, a PE ratio of 18.54 and a beta of 0.35. Pfizer Inc. has a 1-year low of $23.11 and a 1-year high of $28.75. The stock has a 50-day moving average of $25.63 and a 200-day moving average of $26.23. The company has a current ratio of 1.25, a quick ratio of 0.94 and a debt-to-equity ratio of 0.67.

Pfizer (NYSE:PFE) last posted its quarterly earnings results on Tuesday, May 5th. The biopharmaceutical company reported $0.75 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.72 by $0.03. The business had revenue of $14.45 billion for the quarter, compared to analyst estimates of $13.84 billion. Pfizer had a return on equity of 19.44% and a net margin of 11.83%.Pfizer’s revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period last year, the company earned $0.92 EPS. Pfizer has set its FY 2026 guidance at 2.800-3.000 EPS. As a group, sell-side analysts forecast that Pfizer Inc. will post 2.99 EPS for the current year.

Pfizer Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 1st. Stockholders of record on Friday, July 24th will be issued a $0.43 dividend. The ex-dividend date is Friday, July 24th. This represents a $1.72 annualized dividend and a dividend yield of 7.1%. Pfizer’s dividend payout ratio (DPR) is currently 131.30%.

About Pfizer

Pfizer Inc (NYSE: PFE) is a multinational biopharmaceutical company headquartered in New York City. Founded in 1849 by Charles Pfizer and Charles Erhart, the company researches, develops, manufactures and commercializes a broad range of medicines and vaccines for human health. Its activities span discovery research, clinical development, regulatory affairs, manufacturing and global commercial distribution across multiple therapeutic areas.

Pfizer’s portfolio and pipeline cover oncology, immunology, cardiology, endocrinology, rare diseases, hospital acute care and anti-infectives, along with a substantial vaccine business.